JSC Pharmstandard (Russian: ПАО "Фармстандарт", romanized: PAO "Farmstandart") is a Russian multinational[4] pharmaceutical company.[5] It is headquartered in Dolgoprudny, Moscow Oblast.
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 2003 |
| Headquarters | Dolgoprudny, Russia |
Area served | Worldwide |
Key people | Viktor Kharitonin (Chairman) Igor Krylov (CEO) |
| Products | Remedies |
| Revenue | $638 million[1] (2017) |
| $231 million[2] (2016) | |
| $119 million[2] (2016) | |
| Total assets | $1.41 billion[2] (2016) |
| Total equity | $936 million[2] (2016) |
Number of employees | 6,450[3] (2015) |
| Website | pharmstd.com |
Pharmstandard's makes and exports over 400 generic and proprietary drugs, including products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc.[citation needed]
The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.
History edit
Pharmstandard was established in 2003 as a result of a merger.[5]
In May 2007 the company raised $880 million in an IPO, valuing the company at $2.2 billion.[6] Roman Abramovich owned a 17% stake in the company until March 2008.[7]
In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard shares to fall 25%.[8]
Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.[9][10]
References edit
- ^ "Рейтинг крупнейших компаний России по объему реализации продукции". Expert RA. Archived from the original on 28 October 2018. Retrieved 28 October 2018.
- ^ a b c d Error: Unable to display the reference properly. See the documentation for details.
- ^ Error: Unable to display the reference properly. See the documentation for details.
- ^ Pharmstandard International
- ^ a b Anatoly, Zhuplev (2014). Geo-Regional Competitiveness in Central and Eastern Europe, the Baltic Countries, and Russia. IGI Global. p. 228. ISBN 9781466660557.
- ^ Spikes, Salamander Davoudiand Sarah (5 May 2007). "Russian drug IPO raises $880m". Financial Times. Retrieved 25 September 2017.
- ^ "Russia's Abramovich sells his stake in drug maker". Reuters. 2008. Retrieved 25 September 2017.
- ^ "Pharmstandard to buy ingredient supplier for $590 million". Reuters. 2013. Retrieved 25 September 2017.
- ^ "BRIEF-Pharmstandard shares to be delisted as of March 24 - Moscow Exchange". Reuters. 17 February 2017. Retrieved 23 April 2017.
- ^ "Об исключении ценных бумаг из Списка ценных бумаг, допущенных к торгам, и о прекращении торгов ценными бумагами". Московская Биржа. Retrieved 28 August 2017.